Addressing the Challenges Associated with Current HIV Diagnostic Algorithms Barbara G. Werner, PhD ID Consultant, MA State Laboratory 2007 HIV Diagnostics.

Slides:



Advertisements
Similar presentations
Nick Curry, MD, MPH Infectious Diseases Prevention Section
Advertisements

Combined Rapid and HIV RNA Testing in a Public STD Clinic: San Francisco, Jeffrey D. Klausner, Susan Philip, Katherine Ahrens, Giuliano Nieri,
High Throughput Donor Plasma NAT Screening Assay Applied to Acute HIV Detection in a Public Health Setting December 5, 2007 Josh Goldsmith, Ph.D. National.
Post Marketing Surveillance of Oraquick Rapid HIV Testing Laura Wesolowski, PhD Gale R Burstein, MD, MPH Julia Zhu, MS Steven Ethridge, MT Division of.
Implementing a Laboratory-Based Rapid HIV Testing Algorithm using Two Different Test Kits in a Hospital Emergency Department Jason S. Haukoos 1, MD, MSc,
Performance of Bio-Rad Genetic Systems HIV-1/HIV-2 Plus O EIA Followed by Multispot or OraQuick Advance in a Dual Immunoassay HIV Testing Strategy Laura.
Comparative Performance of Dual 3rd Generation Immunoassays as a Potential Laboratory-Based HIV-1/2 Testing Strategy. B. Bennett, S. Fordan, O. David,
Results of a Pilot Point-of-Care (POC) HIV Testing Program using INSTI HIV in an Urban Sexual Health Clinic in Canada Presentation to: 2007 HIV Diagnostics.
Evaluation of HIV Rapid Diagnostic Devices National STD Prevention Conference San Diego, CA 6 March 2002 Jennifer A. Malia, MS, MT WRAIR.
Resolution of Discordant Confirmatory Results on POC Reactive Rapid Tests: Florida’s Pilot Project HIV Diagnostics: New Developments and Challenges Feb.
Supplemental Testing of Donors for HIV and HCV September 18, 2003 BPAC Meeting Robin Biswas, M.D. Indira Hewlett, Ph.D. FDA/CBER/OBRR/DETTD.
Validating 16 Member Pooled APTIMA® HIV-1 RNA testing Ethridge Steven F, Sullivan T, Bennett B, Parker M, Hanson D, Hilliard J, Hart C, Patel P Diagnostic.
Comparing the New EIAs with Old Standbys: Florida Bureau of Laboratories Verification Data HIV Diagnostics: New Developments and Challenges Feb. 28, 2005.
Implementing screening for acute HIV infection in STD clinics already using rapid HIV antibody testing, New York City, 2007 Kathleen D. Gallagher, MPH.
Can Sequentially Reactive EIA’s Replace HIV-1 Western Blot Testing? Robert A. Myers Ph.D.
12/6/07 v.3CDC 2007 HIV Diagnostic Conference1 Diagnosis of HIV-1 Infection in Phase I & II HIV Vaccine Trials RW Coombs 1, J Dragavon 1, B Metch 2, CJ.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
Primary HIV Infection: the CDC study Pragna Patel, MD MPH Medical Epidemiologist Behavioral and Clinical Surveillance Branch DHAP, CDC February 28, 2005.
Epidemiology of HIV-2 infection in the U.S, Lata Kumar MS, MPH Richard Selik MD Division of HIV/AIDS Prevention National Center for HIV/AIDS,
Rapid HIV Testing in an Emergency Department Cook County Bureau of Health Services Chicago, Illinois Centers for Disease Control and Prevention (Cooperative.
Can a second rapid HIV test discriminate false positives as effectively as a Western Blot? The NJ Experience Evan M. Cadoff, MD Robert Wood Johnson Medical.
METHODS  Based on initial OraQuick Post-Marketing Survey, the CDC made the recommendation that a discordant result should be followed-up by antibody testing.
Region I Advisory Board Meeting Wells Beach, ME June 9, 2008 Use and Verification of STD Nucleic Acid Amplification Tests for non-FDA Cleared Clinical.
Alere TM HIV Combo Yuko Tamanoue, Product Development Department.
Oral Presentation 2002 National STD Prevention Conference San Diego, California March 6, 2002 Presenting Author: Karen Kroc (312)
Evaluation of Commercially Available HIV Assays to Address Alternative Screening/Diagnostic Algorithms S. Michele Owen, Ph.D. Laboratory Branch Division.
Testing HIV-Ab Negative High Risk Individuals for HIV RNA Sally Liska, DrPH, Director San Francisco PH Laboratory February 28, 2005 Orlando, FL.
HIV Testing CDC power point edited by M. Myers
Guidelines for Laboratory Testing and Result Reporting for Antibody to Hepatitis C Virus Miriam J. Alter, Ph.D. Division of Viral Hepatitis Centers for.
HIV Diagnosis: New Tests, New Algorithms and a New Focus Berry Bennett, MPH Retrovirology Section Chief FL Bureau of Public Health Laboratories, FDOH
APHL Survey HIV Diagnostic Testing Utilization Barbara G. Werner, PhD MA State Laboratory Institute February 28, 2005.
Shelley Facente, Thomas Knoble, Omar Menendez, Teri Dowling San Francisco Department of Public Health, HIV Prevention Section Kevin Delaney Division of.
HIV Rapid Testing Dr. Kevin Harvey National HIV/AIDS Programme Ministry of Health Jamaica.
Screening for Acute HIV-1 Infection at NYC DOHMH Public Health Laboratory William R. Oleszko, Ph.D. Associate Director, Public Health Laboratory Department.
Incorporation of the Aptima® HIV-1 RNA Assay into Serodiagnostic and Rapid Test Confirmation Testing Algorithms to Resolve Discordant Serological Results.
HIV Testing Quality Assurance and Quality Control
Results from the LA rapid testing study: What can they tell us about proposed point of care strategies? Kevin Delaney, MPH Division of HIV/AIDS Prevention.
Implementing Rapid HIV Testing in the United States Bernard M. Branson, M.D. Centers for Disease Control and Prevention Overview and Background.
CLINICAL TRIAL OF THE HEMA-STRIP HIV RAPID TEST USING FINGERSTICK BLOOD, WHOLE BLOOD, PLASMA, AND SERUM Niel T. Constantine 1, Dan Bigg 2, Daniel Cohen.
Performance of rapid HIV tests used singly and in combination: Moving toward a point of care diagnosis. Kevin Delaney, MPH HIV Diagnostics: New Developments.
Figure 1 A Case Series of Discordant Laboratory Results with Statewide Rapid HIV Testing in New Jersey Eugene G Martin, PhD 1, Gratian Salaru, MD 1, Sindy.
APHL Update – FDA Cooperative agreement. The Association of Public Health Laboratories (APHL) has been actively working towards meeting the deliverables.
RESULTS Rapid testing started at one publicly funded counseling and testing site in New Jersey on November 1, Through December 31, 2004, 48 sites.
Implementing a Rapid HIV Testing Guideline for L&D NNEPQIN April 30, 2007.
Reducing the Delay: Can a Rapid HIV Test Discriminate False Positives as Effectively as a Western Blot – the NJ Experience Eugene G. Martin, Ph.D. *, Gratian.
Region I Laboratory Update CDC National Infertility Prevention Project Boston, Massachusetts November 15, 2010 Richard Steece, Ph.D., D(ABMM) Laboratory.
PEPFAR Plans for Initiating ART and Providing Laboratory Services Tedd V. Ellerbrock, MD, FACOG Global AIDS Program Centers for Disease Control and Prevention.
In the Footsteps of the WHO – Rapid HIV Testing in America Eugene Martin, Ph.D. *, Gratian Salaru, M.D. *, Sindy M. Paul, M.D., M.P.H.**, Evan Cadoff,
E001372A 1 ARC Experience with Indeterminate Blood Donors Susan L. Stramer, Ph.D. National Confirmatory Testing Laboratory American Red Cross.
TNI Advocacy Program Update AURORA SHIELDS. ADVOCACY COMMITTEE  Judy Duncan  Marlene Moore  Kenneth Jackson  Barbara Finazzo  Kevin Coast  Lara.
Issues Related to Implementation of Blood Donor Screening for Infection with Trypanosoma cruzi Presentation to BPAC April 26, 2007 Robert Duncan, PhD.
Update Rapid HIV Test Approval Requirements and Standards BPAC September 15, 2000 Kimber Poffenberger, Ph.D.
Bernard M. Branson, M.D. Associate Director for Laboratory Diagnostics Divisions of HIV/AIDS Prevention National Center for HIVAIDS, Viral Hepatitis, STD,
Call in number: Conference code: NBSTRN SCID National Call November 18, 2011.
Test 1Test 2Test 3Test 4Test 5Test 6 Sensitivity Specificity PPV NPV Performance.
CLIA Waiver for the OraQuick ® Rapid HIV-1 Antibody Test Elliot P. Cowan, Ph.D. Senior Regulatory Scientist Office of Blood Research and Review Center.
ABSTRACT Purpose: Point-of-care rapid HIV testing is a new way to diagnose HIV disease. The New Jersey Department of Health and Senior Services Division.
If the serum specimen fails to confirm, the frozen white top tube is collected by staff from NJ HIV and sent frozen overnight to ARUP laboratories (Salt.
Bernard M. Branson, M.D. Associate Director for Laboratory Diagnostics Divisions of HIV/AIDS Prevention National Center for HIV, STD, and TB Prevention.
CONCLUSIONS New Jersey’s Emergency Department HIV testing sites report higher seroprevalence than non-ED testing sites. Since University Hospital began.
California Clinical Laboratory Association
In the Footsteps of the WHO – Rapid HIV Testing in America
Post Test Counseling & Referral
San Francisco Department of Public Health
AIDS in the United States
1985: First HIV-1 ELISA Approved by FDA
A CASE SERIES OF DISCORDANT LABORATORY RESULTS WITH RAPID HIV TESTING
Toward a More Perfect World
Challenges for Blood Donor Confirmatory Testing Algorithms
Presentation transcript:

Addressing the Challenges Associated with Current HIV Diagnostic Algorithms Barbara G. Werner, PhD ID Consultant, MA State Laboratory 2007 HIV Diagnostics Conference December 5-7, 2007

HIV Testing Algorithms Standard from 1980s for laboratory testing –EIA screen, repeat reactive samples in duplicate, repeatedly reactive samples tested by WB or IFA –Already alternative algorithms in use in blood banks, in some US and international settings POC recommendations –All reactive specimens should be followed up with a WB, IFA, or an HIV RNA test to confirm the result

Challenges with Currently Recommended Diagnostic Algorithms More recently FDA approved tests not included Western blot and IFA now less sensitive than some screening assays Questions about how to deal with indeterminates Lack of FDA approved HIV-2 confirmatory tests Developed using assays as screening or confirmatory/supplemental tests not as part of multi-test algorithms Need for laboratory confirmation of POC rapid tests

Process for Developing New HIV Testing Algorithms APHL/CDC HIV Steering Committee –Priority to develop new algorithms with directives from APHL Board of Directors, CDC Algorithm Workgroups –Point of care (POC) and Laboratory Data gathering –retrospective and prospective efforts

APHL/CDC HIV Algorithm Workgroups’ Goal Develop multiple acceptable HIV testing algorithms, i.e., a menu of options, including recommendations for use, reporting, follow up, and referral

Lab and POC Workgroup Members Berry Bennett * Robert Bormisa Bernard Branson * Michael Busch Evan Cadoff Sheldon Campbell Elliot Cowan * David Cross Kevin Delaney Teri Dowling Steven Ethridge Shelley Facente Richard Hodinka Marcia Kalish Jan King Sally Liska * Brian Louie Steve McDougal Duncan Mackellar Eugene Martin

Lab and POC Workgroup Members Joanne Mei William Meyer Robert Myers * Robert O’Connell Michele Owen * Mark Pandori Sindy Paul Pragna Patel Sheila Peel *Steering Committee Member Michael Pentella * Liisa Randall Mark Rayfield * Natalie Rice * Travis Sanchez * Susan Stramer Anthony Tran * Barbara Werner *

Organizations, Agencies and Groups Represented on Workgroups APHL ACLA ASM Blood Banks CAP CDC Clinical Labs DoD FDA HIV Program Staff

Issues to keep in mind with wider use of HIV tests QA in non-laboratory settings Reporting to PH authorities Varying state regulations Appropriate follow up testing and referrals False positives in low risk individuals –PPV can be low in asymptomatic persons Maintenance of laboratory infrastructure Financial support

Current Charge Listen to presentations and look at posters Consider –Which proposed algorithms are supported by existing data –What additional information is needed –Where appropriate to use each algorithm –Who else ought to have a say in when and where particular algorithms should be used –Implementation and performance monitoring

With thanks to … Steve Ethridge, Amanda Smith, and Laura Wesolowski, CDC Anthony Tran and Natalie Rice, APHL APHL/CDC Steering Committee and Workgroup Colleagues